These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36777569)

  • 21. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
    Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
    Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
    Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.
    Pan G; Li T; Zeng Q; Wang X; Zhu Y
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26861264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles.
    Liu S; Li R; Qian J; Sun J; Li G; Shen J; Xie Y
    Mol Pharm; 2020 Apr; 17(4):1415-1427. PubMed ID: 32159961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.
    Yang L; Li M; Wang F; Zhen C; Luo M; Fang X; Zhang H; Zhang J; Li Q; Fu L
    Cell Physiol Biochem; 2018; 46(6):2487-2499. PubMed ID: 29742496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell lines.
    Xu HB; Li L; Liu GQ
    Chemotherapy; 2011; 57(1):62-70. PubMed ID: 21282948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TanshinoneIIA enhances the chemosensitivity of breast cancer cells to doxorubicin through down-regulating the expression of MDR-related ABC transporters.
    Li K; Lai H
    Biomed Pharmacother; 2017 Dec; 96():371-377. PubMed ID: 29028589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
    Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
    Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges".
    Kam Y; Das T; Tian H; Foroutan P; Ruiz E; Martinez G; Minton S; Gillies RJ; Gatenby RA
    Int J Cancer; 2015 Feb; 136(4):E188-96. PubMed ID: 25156304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
    Huang M; Jin J; Sun H; Liu GT
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1015-26. PubMed ID: 18270702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
    Ni R; Zhu J; Xu Z; Chen Y
    J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo.
    Guo X; To KKW; Chen Z; Wang X; Zhang J; Luo M; Wang F; Yan S; Fu L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):31. PubMed ID: 29458405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells.
    Shen Q; Qiu L
    J Liposome Res; 2017 Dec; 27(4):293-301. PubMed ID: 27581212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.
    Zhang Y; Pullambhatla M; Laterra J; Pomper MG
    Mol Imaging; 2012; 11(6):499-506. PubMed ID: 23084250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.